Cancer, Breast Clinical Trial
Official title:
Effects of a Physical Exercise and Health Education Program for Women With Breast Cancer Undergoing Chemotherapy
The purpose of this study is to verify the effect of the intervention of a program of physical exercises and health education in women with breast cancer undergoing chemotherapy.
According to the National Cancer Institute (INCA), the estimate for Brazil, 2016-2017 biennium, points to the occurrence of about 600,000 new cases of cancer, and breast cancer (58000) in women will be the most frequent. One study revealed that only 12% of women undergoing chemotherapy in CM who participated in a physical exercise program had to readjusted the dose of the medications, while 34% of those who received the conventional treatment needed to readjust the Treatment doses, with neuropathy being one of the most present adverse effects that influenced this adjustment. In this sense, the conduct to keep the patient at rest during the treatment seems to potentiate her side effects, and sedentarism is another factor detrimental to the patient's health. Objective: To verify the effect of the intervention of a program of physical exercises and health education in women with breast cancer undergoing chemotherapy. Methodology: A sample will consist of 136 (136) Women, over 18 years of age, sedentary, diagnosed with non-metastatic breast cancer and initiating the first cycle of chemotherapy. They will be divided into two groups, randomly and stratified: control group: (CG n = 68) and exercise group: (eg n = 68) that will undergo a supervised training program of combined exercises for 24 weeks, with a frequency of 3 times Weekly and duration of 60 minutes, an unsupervised flexibility training program 2 times a week and both groups (GC and EG) will attend lectures on health education, which are held monthly. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04416087 -
Exercise and Tumor Blood Flow in Breast Cancer Patients
|
N/A | |
Active, not recruiting |
NCT04726319 -
Family History App in Personalized Medicine
|
N/A | |
Completed |
NCT04692168 -
Influence of Chemotherapy on Postural Control in Women With Cancer
|
||
Recruiting |
NCT03709134 -
Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy
|
||
Completed |
NCT03282214 -
A Self-Management Energy Conservation Program for Cancer-Related Fatigue
|
Phase 2 | |
Recruiting |
NCT05711030 -
Thoracic Paravertebral Block Anesthesia for Breast Cancer Surgery
|
N/A | |
Suspended |
NCT03271853 -
Thermalogical Analysis of a Cohort of Women and Men Undergoing Mammographic Analysis.
|
N/A | |
Active, not recruiting |
NCT03144947 -
Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Trastuzumab in HER2+ Breast Cancer Patients
|
Phase 2 | |
Completed |
NCT02996201 -
Electronic Patient Reporting of Side Effects to Chemotherapy: A Cluster Randomized Controlled Trial
|
N/A | |
Active, not recruiting |
NCT03282097 -
Decisions About Cancer Screening in Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05573022 -
Impact of a Patient Decision Aid Intervention
|
N/A | |
Recruiting |
NCT05161312 -
A Guided Online Intervention to Improve Quality of Life in Breast Cancer Patients - a Randomised Clinical Trial
|
N/A | |
Active, not recruiting |
NCT04836221 -
Comorbidities And Reducing inEquitieS
|
N/A | |
Not yet recruiting |
NCT03910283 -
Leveraging Mindsets to Improve Health & Wellbeing in Patients With Cancer
|
N/A | |
Completed |
NCT03612934 -
The Impact of SPC on Advanced Breast Cancer Patients
|
||
Recruiting |
NCT03301493 -
Genomic Testing and Resulting Medical Decisions
|
||
Completed |
NCT04352530 -
Culturally Appropriate Nutrition Communication for Mexican American Women
|
N/A | |
Active, not recruiting |
NCT05830097 -
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT02991677 -
Exercise Effect on Chemotherapy-Induced Neuropathic Pain
|
N/A | |
Active, not recruiting |
NCT04971304 -
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
|